Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia

PHASE4CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

March 18, 2019

Primary Completion Date

December 23, 2019

Study Completion Date

January 30, 2020

Conditions
Tardive Dyskinesia (TD)
Interventions
DRUG

Valbenazine

vesicular monoamine transporter 2 (VMAT2) inhibitor

DRUG

Placebo oral capsule

non-active dosage form

Trial Locations (43)

10029

Neurocrine Clinical Site, New York

18503

Neurocrine Clinical Site, Scranton

19428

Neurocrine Clinical Site, Conshohocken

23805

Neurocrine Clinical Site, Petersburg

32803

Neurocrine Clinical Site, Orlando

33012

Neurocrine Clinical Site, Hialeah

33013

Neurocrine Clinical Site, Hialeah

33018

Neurocrine Clinical Site, Hialeah

33161

Neurocrine Clinical Site, North Miami

33183

Neurocrine Clinical Site, Miami

37067

Neurocrine Clinical Site, Franklin

44030

Neurocrine Clinical Site, Houston

44122

Neurocrine Clinical Site, Beachwood

45040

Neurocrine Clinical Site, Mason

46601

Neurocrine Clinical Site, South Bend

48302

Neurocrine Clinical Site, Bloomfield Hills

48824

Neurocrine Clinical Site, East Lansing

49503

Neurocrine Clinical Site, Grand Rapids

63109

Neurocrine Clinical Site, St Louis

64108

Neurocrine Clinical Site, Kansas City

68526

Neurocrine Clinical Site, Lincoln

72211

Neurocrine Clinical Site, Little Rock

73112

Neurocrine Clinical Site, Oklahoma City

75062

Neurocrine Clinical Site, Irving

75115

Neurocrine Clinical Site, DeSoto

77058

Neurocrine Clinical Site, Houston

77407

Neurocrine Clinical Site, Richmond

81003

Neurocrine Clinical Site, Pueblo

89102

Neurocrine Clinical Site, Las Vegas

90502

Neurocrine Clinical Site, Torrance

90631

Neurocrine Clinical Site, La Habra

90650

Neurocrine Clinical Site, Norwalk

91206

Neurocrine Clinical Site, Glendale

91945

Neurocrine Clinical Site, Lemon Grove

92056

Neurocrine Clinical Site, Escondido

92108

Neurocrine Clinical Site, San Diego

92408

Neurocrine Clinical Site, San Bernardino

92627

Neurocrine Clinical Site, Costa Mesa

92708

Neurocrine Clinical Site, Fountain Valley

92804

Neurocrine Clinical Site, Anaheim

92805

Neurocrine Clinical Site, Anaheim

99202

Neurocrine Clinical Site, Spokane

00926

Neurocrine Clinical Site, San Juan

Sponsors
All Listed Sponsors
lead

Neurocrine Biosciences

INDUSTRY